Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Germline GCM2 Mutation Screening in Chinese Primary Hyperparathyroidism Patients.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists - 1 Oct 2020

Song An, Yang Yi, Wang Yabing, Liu Shuzhong, Nie Min, Jiang Yan, Li Mei, Xia Weibo, Wang Ou, Xing Xiaoping

Abstract excerpt

OBJECTIVE: Glial cell missing 2 (GCM2), the critical regulator in the development of parathyroid glands, has been associated with the pathogenesis of primary hyperparathyroidism (PHPT). Relevant data in Chinese and other Asian populations are still lacking. This study aimed to screen the germline mutations of GCM2 in Chinese PHPT patients. METHODS: A total of 232 patients diagnosed with PHPT at the Peking Union...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Asian People
Share to Germ Cells

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Germ-Line Mutation

Share to Hyperparathyroidism, Primary

Share to Mutation

Share to Neuroglia

Share to Nuclear Proteins

Share to Transcription Factors

Source

Identifiers

PMID: 33471711
DOI: 10.4158/EP-2020-0132

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Germline GCM2 Mutation Screening in Chinese Primary Hyperparathyroidism Patients.PMID 33471711Read ↗

Increased prevalence of the GCM2 polymorphism, Y282D, in primary hyperparathyroidism: analysis of three Italian cohorts.Semantic proximity Read ↗

Novel Glial Cells Missing-2 (GCM2) variants in parathyroid disorders.Semantic proximity Read ↗

Ethnicity of Patients With Germline GCM2-Activating Variants and Primary HyperparathyroidismSemantic proximity Read ↗

GCM2-Activating Mutations in Familial Isolated Hyperparathyroidism.Semantic proximity Read ↗

Germline Mutations Related to Primary Hyperparathyroidism Identified by Next-Generation SequencingSemantic proximity Read ↗

GCM2Variants in Familial and Multiglandular Primary HyperparathyroidismSemantic proximity Read ↗

Analysis of Activating GCM2 Sequence Variants in Sporadic Parathyroid AdenomasSemantic proximity Read ↗

Identification and characterization of novel parathyroid-specific transcription factor Glial Cells Missing Homolog B (GCMB) mutations in eight families with autosomal recessive hypoparathyroidism.Semantic proximity Read ↗

Comprehensive next-generation sequencing analyses of hypoparathyroidism: identification of novel GCM2 mutations.Semantic proximity Read ↗

Genomic Profiling Reveals the Variant Landscape of Sporadic Parathyroid Adenomas in Chinese Population.Semantic proximity Read ↗

Familial isolated primary hyperparathyroidism associated with germline GCM2 mutations is more aggressive and has a lesser rate of biochemical cureSemantic proximity Read ↗

Presence and significance of a R110W mutation in the DNA-binding domain of GCM2 gene in patients with isolated hypoparathyroidism and their family members.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.